{{Rsnum
|rsid=1296028
|Gene=CTSB
|Chromosome=8
|position=11841238
|Orientation=plus
|GMAF=0.1635
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 37.2 | 10.6
| HCB | 81.6 | 16.9 | 1.5
| JPT | 85.0 | 14.2 | 0.9
| YRI | 87.1 | 12.9 | 0.0
| ASW | 78.9 | 21.1 | 0.0
| CHB | 81.6 | 16.9 | 1.5
| CHD | 81.7 | 17.4 | 0.9
| GIH | 61.0 | 32.0 | 7.0
| LWK | 79.1 | 20.9 | 0.0
| MEX | 72.4 | 22.4 | 5.2
| MKK | 90.4 | 9.6 | 0.0
| TSI | 56.9 | 37.3 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22451204
|Trait=None
|Title=Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
|RiskAllele=
|Pval=0.000001
|OR=1.1500
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=18636124
|Title=Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}